Scarica l'app Stockscreener
1.95
0.00%
0.00
Precedente Chiudi:
$1.95
Aprire:
$1.9
Volume 24 ore:
3,880
Relative Volume:
33.09
Capitalizzazione di mercato:
$N/A
Reddito:
$3.07M
Utile/perdita netta:
$-26.16M
Rapporto P/E:
-0.1618
EPS:
-12.05
Flusso di cassa netto:
$-17.84M
1 W Prestazione:
+4.21%
1M Prestazione:
-36.27%
6M Prestazione:
-57.97%
1 anno Prestazione:
+14.04%
Intervallo 1D:
$1.90
$1.95
Intervallo di 1 settimana:
$1.90
$1.95
Portata 52W:
$1.90
$1.95
Opgen Inc Stock (OPGN) Company Profile
Confronta OPGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| OPGN | 1.95 | 0 | 3.07M | -26.16M | -17.84M | -12.05 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Opgen Inc Stock (OPGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-03-01 | Iniziato | Alliance Global Partners | Buy |
| 2018-02-07 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-29 | Iniziato | Rodman & Renshaw | Buy |
Opgen Inc Borsa (OPGN) Ultime notizie
OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
OpGen Inc (OPGN) Quarterly 10-Q Report - Quartzy
Biophotonics Global Market Observe Highest Growth of $130.07 - openPR
OpGen secures additional $6 million financing, extends agreement to 2025 By Investing.com - Investing.com Australia
OpGen secures additional $6 million financing, extends agreement to 2025 - Investing.com India
AEI Capital Ltd reports stock transactions in OpGen Inc - Investing.com
AEI Capital Ltd reports stock transactions in OpGen Inc By Investing.com - Investing.com Canada
TG Investment Ltd. Take up 7% Stake in OpGen, Inc. with Shares Traded Across Multiple Exchanges - openPR
OpGen (NASDAQ:OPGN) Research Coverage Started at StockNews.com - Defense World
Optical Genome Mapping Market Size and Emerging Trends - Economica
Sepsis Diagnostics Market Analysis: Key Trends, Growth Drivers and Key Companies - Newstrail
Optical Genome Mapping Market 2024 Key Insights - Economica
Antimicrobial Resistance Surveillance Market Worth $7.7 Billion By 2028 As Revealed In New Report - WhaTech
Clinical Microbiology Global Market Insights Discussed Regarding Report 2024Statistics, Analysis - WhaTech
Optical Genome Mapping Market Future Path Key Industry Insights to 2031 – news - Global Reverse Circulation ...
Point of Care Molecular Diagnostics Market Trends and Strategy: $3.4 Billion Industry by 2028 As Revealed I... - WhaTech
Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News
Antimicrobial Resistance Surveillance Market Size Report 2032 By Top Research Firm - WhaTech
Biophotonics Market Insights Discussed Regarding Size, Share, Trends Outlook And Global Forecast 2024 To 2033 - WhaTech
OpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing - TipRanks
OPGN Stock Earnings: OpGen Reported Results for Q2 2024 - InvestorPlace
OpGen discloses restatement of Q1 2024 financials due to error - Investing.com India
OpGen discloses restatement of Q1 2024 financials due to error By Investing.com - Investing.com UK
OpGen (OPGN) Free Cash Flow : $-10.91 Mil (TTM As of Mar. 2024) - GuruFocus.com
OpGen Inc appoints five new directors to its board - Investing.com India
OpGen Bolsters Board with Five New Industry Experts - TipRanks
OpGen (NASDAQ:OPGN) Coverage Initiated at StockNews.com - Defense World
Upcoming Opportunities in High-Resolution Genomic Mapping - openPR
OpGen (NASDAQ:OPGN) Now Covered by StockNews.com - Defense World
OpGen announces leadership change and equity transaction - Investing.com India
OpGen Leadership Changes: CEO Resigns, New Chairman Appointed - TipRanks
OpGen announces leadership change and equity transaction By Investing.com - Investing.com UK
StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN) - Defense World
Antimicrobial Resistance Surveillance Market Size to Hit - GlobeNewswire
Antimicrobial Resistance Surveillance Market Size to Hit US$ 9.50 Billion by 2032, Rising Prevalence of Drug-Resistant Infections Drives Growth | Research by SNS Insider - India Shorts
OpGen (NASDAQ:OPGN) Stock Quotes, Forecast and News Summary - Benzinga
OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com - Defense World
[Key Companies] Optical Genome Mapping Instruments Market | OpGen, Inc, Bionano Genomics - Economica
Optical Genome Mapping Market to reach a valuation of USD - GlobeNewswire
Optical Genome Mapping Market to reach a valuation of USD 1.3 billion by 2034, at a CAGR of 23.5% | Future Market Insights, Inc. - Yahoo Finance
OPGN Stock Earnings: OpGen Reported Results for Q1 2024 - MSN
OpGen stock jumps after David Lazar invests $3M, takes over as CEO - MSN
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - Quantisnow
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. ... - Quantisnow
OpGen (NASDAQ:OPGN) Shares Pass Below 50 Day Moving Average of $4.12 - Defense World
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
OpGen to Provide Business Update and Financial Results for the Third Quarter 2022 on November 10th at 4:30 p.m. ... - OpGen, Inc.
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - br.ADVFN.com
OpGen Announces $3.38 Million Registered Direct Offering - br.ADVFN.com
OpGen (NASDAQ:OPGN) Stock Price Passes Below 50 Day Moving Average of $4.76 - Defense World
OPGN Stock Earnings: OpGen Meets Revenue for Q4 2023 - MSN
Opgen Inc Azioni (OPGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.43%
Capitalizzazione:
|
Volume (24 ore):